Aims/Hypothesis-Exercise benefits most, but not all, individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to determine whether a proportion of individuals with T2DM would fail to demonstrate exercise-induced metabolic improvements. We hypothesized that this lack of response would be related to their skeletal muscle transcriptional profile.
Introduction
As many as 40% of Americans will have T2DM within their lifetime [1] . Exercise benefits most individuals with T2DM; however, some people derive significantly less metabolic benefit. We and others have found that ~ 15-20% of individuals fail to increase muscle mitochondrial density and improve their glucose homeostasis and insulin sensitivity after supervised exercise interventions [2] [3] [4] . Recent findings have shown that a genetic predisposition to diabetes can modify ATP flux responses, whereby a single nucleotide polymorphism in a mitochondrial Complex I subunit gene reduces the ability to improve in vivo mitochondrial function with exercise [5] . Furthermore, VO 2 max responses to endurance exercise training can be predicted by a 29-gene RNA expression signature in the pre-trained muscle [6] , while transcriptional data have demonstrated that individuals with insulin resistance have a reduced response of nuclear-encoded mitochondrial genes to acute exercise [7] . These authors have termed this phenomenon "exercise resistance". We hypothesized that individuals with T2DM who did not significantly improve their metabolic status after nine months of supervised exercise would display a blunted response in the basal molecular signature of their skeletal muscle.
Research Design and Methods

Participants
Forty-two men and women from the previously reported HART-D [2] study completed (≥ 80% compliance) the present ancillary study that included the collection of muscle tissue samples at baseline. Details of the methods, inclusion/exclusion criteria and intervention are provided in the main outcomes papers [2, 3] . The study was approved by the Pennington Biomedical Research Center IRB. Written informed consents were obtained.
Body Composition, Blood and Muscle Tissue Analyses
Body composition was measured by DXA (QDR 4500A, Hologic). Fasting blood samples [3] and muscle samples were obtained and assessed as previously described [2, 3] .
Mitochondrial DNA (mtDNA) Quantification
Total DNA was isolated from ~ 10 mg of skeletal muscle tissue and relative amounts of mtDNA and nuclear DNA were determined by Real Time qPCR as previously described [3] .
RNA Isolation, Illumina Chips, qRT-PCR and Statistical Analysis
Total RNA was isolated from ~ 20 mg of skeletal muscle tissue using the RNeasy Fibrous Tissue kit (Qiagen). Near-whole-genome transcriptome analysis was performed using the Illumina bead-based technology and Sentrix Human-6 V2 Expression BeadChip (Illumina). One chip was used per participant. Quantile normalization, multiple imputation and log2-transformation were followed by gene differential analysis using the two-sample t-test. A heat-map was prepared using an unsupervised two-way cluster analysis.
Real-Time Quantitative RT-PCR (qRT-PCR)
Primer-probe sets were pre-designed Single Tube Taqman® gene expression assays. qRT-PCR reactions were performed using Taqman Fast Virus 1-step reaction mix Standard protocol (Life Technologies). Data were normalized by dividing the target gene by the geometric mean of internal control genes (Actin B and GAPDH).
Differences in gene expressions between Responders and Non-Responders were compared using a two-sample t-test. Statistical significance was set as type I error < 0.05.
Results and Discussion
Participants were randomized to nine months of aerobic (AT), resistance (RT), combination training (ATRT), or a non-exercise control group. Since responses were similar across groups, the three exercise groups were collapsed. The control group was not evaluated for these analyses. In contrast to our findings, others report differences between AT and RT responses in obese adolescents [8] , however this discrepancy may be due to cohort differences between the studies. Several primary metabolic parameters were used to determine the integrated response (or lack thereof) to exercise among study participants: (1) HbA 1c , (2) muscle mtDNA content, (3) percent body fat and (4) BMI. We performed principal components analysis (PCA) based on these metabolic outcomes. Two distinct groups (n = 9 each) emerged from the PCA analysis and were categorized as 'NonResponders' and 'Responders' based on Eigenvalue (data not shown). A Responder was defined a priori as having decreased HbA 1c , percent body fat and BMI, and increased muscle mtDNA content.
In contrast to Responders, Non-Responders did not exhibit significant decreases in HbA 1c levels, percent body fat or BMI. Intriguingly, Non-Responders decreased mtDNA content after exercise compared with Responders. There were no significant differences between the groups based on gender or age (Fig. 1A) . These findings support the premise of "exercise resistance", and validate the use of the metabolic panel examined herein as a means of defining "exercise resistance" in individuals with T2DM.
Microarray analysis of baseline gene expression in skeletal muscle confirmed the distinction between Non-Responders and Responders. A 'hit list' of 186 genes generated from this data showed differential mRNA expressions between the two groups, with down-regulation of ~ 70% of genes on the 'hit list' observed in Non-Responders (Fig. 1B) . Even more compelling was the discovery that ~ 25% of these differentially expressed genes were involved in substrate metabolism and mitochondrial biogenesis/function (Fig. 1C) . Admittedly, certain classes of low expression genes may be absent from this method of analysis due to detection limitations. Ingenuity Pathway Analysis (IPA) was used to define and depict these functional associations of genes from the 'hit list' and the literature, as well as pathways by which these genes are connected ( Fig. 2A) . Similar analyses by others have identified disparities in transcriptomes of pre-trained skeletal muscle, which suggested that heterogeneity of hypertrophic responses to resistance training was predetermined [9] .
qRT-PCR analyses of a selection of genes from both the 'hit list' and IPA, revealed five of seven genes analyzed were significantly down-regulated in Non-Responders compared with Responders (Fig. 2B) . These data suggest that the lack of response in Non-Responders is linked to down-regulation of exercise-responsive genes. PPARα and ELOVL1, which play a role in lipid metabolism, as well as CHKB, CISD2 and FOXO1, which are involved in mitochondrial function, displayed decreased mRNA expressions in Non-Responders vs. Responders. Interestingly, FOXO1 which is up-regulated in skeletal muscle in response to contractile signals [10], was identified by IPA analysis and was also significantly downregulated in Non-Responders.
The down-regulation of exercise-and substrate metabolism-linked genes in Non-Responders strongly suggests that the lack of response to exercise in these individuals is transcriptionally modulated. Barres et al. reported that a single, acute bout of exercise is sufficient to induce hypomethylation of the promoters of genes involved in mitochondrial function and fuel usage, resulting in increased mRNA expressions [11] . In support of this programmed response, McGee et al. reported increased histone acetylation associated with transcriptional elongation, immediately following acute exercise [12] . Furthermore, a six-month long exercise intervention resulted in differential DNA methylation profiles in skeletal muscle [13] . Thus, the disparate gene expressions observed between Non-Responders and Responders may be the result of differentially modified chromatin. Our current findings point toward a basal molecular signature of human skeletal muscle as a key factor in the ability to respond to exercise.
Conclusions
In this study of individuals with T2DM, we distinguished Non-Responders from Responders following a 9-month supervised exercise intervention based on changes in a pre-defined set of metabolic outcomes. The expressions of exercise-responsive genes reflected in quantifiable metabolic parameters suggest that identification and subsequent targeting of transcriptional biomarkers linked to "exercise resistance" could effectively translate into measurable physiological and metabolic responses.
While very little is known about the underlying mechanisms of "exercise resistance", substantial evidence suggests that this phenomenon is heritable [5] [6] [7] . The particular strength of this study is the novelty of the discovery of differential basal muscle gene expressions linked to "exercise resistance". These findings provide compelling insight into the molecular signature and potential predictability of the programmed failure to respond to exercise. With the gradual shift toward a more personalized approach to patient care, the elucidation of the mechanisms of "exercise resistance" may provide a pivotal step in revolutionizing the treatment of T2DM. Understanding the programmed lack of response to exercise in some individuals with T2DM will be critical to the development of therapeutics that will circumvent the "transcriptional block" to the benefits of exercise. 
